Home
        Hologic FV IVD Package Insert
         Contents
1.    Warranty Period    Replacement parts are warranted for the remainder of the  Warranty Period or ninety  90  days from Delivery  whichever is longer  Consumable Supplies  are warranted to conform to published specifications for a period ending on the expiration date  shown on their respective packages  Services are warranted to be supplied in a workman like  manner  Hologic does not warrant that use of Products will be uninterrupted or error free  or  that Products will operate with non Hologic authorized third party products  HOLOGIC S  ENTIRE WARRANTY RESPONSIBILITY IS EXPRESSLY LIMITED TO REPAIR OR  REPLACEMENT  AT HOLOGIC S OPTION AND IN THE FORM ORIGINALLY SHIPPED  OF  PRODUCT OR CORRECTION OF SERVICE SUBJECT TO ANY CLAIM  OR  AT HOLOGIC S  ELECTION  REPAYMENT OF  OR CREDITING CUSTOMER WITH  AN AMOUNT EQUAL  TO THE HOLOGIC PRICE  FEE OR CHARGE THEREFORE  THE FOREGOING  WARRANTIES ARE IN LIEU OF AND EXCLUDE ALL OTHER WARRANTIES NOT  EXPRESSLY SET FORTH HEREIN  WHETHER EXPRESS OR IMPLIED BY OPERATION  OF LAW OR OTHERWISE  INCLUDING BUT NOT LIMITED TO ANY IMPLIED  WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE   SUCH LIMITED WARRANTY IS GIVEN SOLELY TO THE ORIGINAL CUSTOMER AND IS  NOT GIVEN TO  NOR MAY IT BE RELIED UPON BY  ANY THIRD PARTY INCLUDING   WITHOUT LIMITATION  CUSTOMERS OF CUSTOMER  THIS WARRANTY IS VOID UPON  TRANSFER OF PRODUCT BY CUSTOMER TO ANY ENTITY WHO HAS LESS THAN FIFTY   50  PERCENT OWNERSHIP IN THE PRODUCT  SOME STATES DO NOT ALLO
2.   DVT Study  Arch Intern Med  1991 151 933 938    4  Spector EB  Grody WW  Matteson CJ et al  Technical standards and guidelines  venous  thromboembolism  Factor V Leiden and prothrombin 20210G  gt A testing   a disease specific  supplement to the standards and guidelines for clinical genetics laboratories  Genet Med 2005   7 6  444 53    5  Ridker PM  Miletich JP  Hennekens CH  Buring JE  Ethnic distribution of factor V Leiden in 4047  men and women  Implications for venous thromboembolism screening    JAMA 1997  277 16  1305 7     VI  CONTACT INFORMATION  Manufactured and distributed by Hologic Inc   Madison  WI  USA     For further technical information or to order product  contact     Phone  608 273 8933  Toll free  1 888 898 2357    Hologic Inc   502 South Rosa Road  Madison  WI 53719 1256    VII  NOTICE TO RECIPIENT ABOUT LIMITED LICENSE    The receipt of this product from Hologic  Inc  or its authorized distributor includes a limited  non   exclusive license under patent rights held by Hologic  Inc  Acquisition of this product constitutes  acceptance by the recipient of this limited license  Recipients unwilling to accept the limited license  must return the product for a full refund  Such license is solely for the purposes of using this product  to detect a specific analyte  For avoidance of doubt  the foregoing license does not include rights to  use this product for agriculture or veterinary medicine applications  The foregoing license does not  include a license to
3.   If results are invalid or not displayed  refer to the  Troubleshooting section of this package insert or in the Software User Manual for Invader    Factor V  MAN 01688      If any of the controls are invalid  sample results will not be displayed   D  Limitations    General Limitations    Reagents may demonsirate unexpected performance in previously untested samples  The  possibility of unexpected performance even in tested blood samples cannot be completely  eliminated due to the biological variability of sample matrices  Contact Hologic Technical Support   888 898 2357  with any documented unexpected result s      Specific Limitations    The Factor V Leiden  FVL  mutation is G1691A  Additional rare mutations in Factor V include  A1692C  G1689A and A1696G  It is recommended that the laboratory assess the possibility of  rare Factor V mutations to generate false FVL results and report this as a limitation  if  applicable     E  Summary of Performance Characteristics  1  Accuracy compared to bi directional DNA Sequencing    Human whole blood samples  n   352  underwent DNA extraction and subsequent bi directional  DNA sequence analysis  The same DNA samples were then analyzed using the Invader   Factor  V test  The observed agreement between the Invader   Factor V test and bi directional DNA  sequencing was 100   352 352   The overall agreement with bi directional sequencing was  100   352 352   with 99 15   one sided lower 95  confidence limit  see Table 5      Page 5 of 9  
4.   Table 5  Agreement between the Invader   Factor V Test and Bi directional DNA Sequencing    Number of  Correct 1  Run  Genotype Calls Agreement  on 1  Run    Run  Homozygous  ie aoe 100     Table 7  Invader   Factor V Test Summary of Agreement Data for all Three Sites    Number of Valid    Factor V Number Tested Results on 1       One Sided  Genotype     Analv  es Number of Number of Percent Lower 95   y Comparisons Agreements Agreement Confidence    x 25  day pairs       aoe pee  omocygous x 3  sites    2700    9  samples   a   a ee 100  Between Sites x 20  tests at site    Genotype determined through bi directional DNA 2   se b   BEN x 3  site pairs     2  Reproducibility 10800       a  Inter laboratory Reproducibility  A multi center external study was conducted to b  Lot to Lot Reproducibility  Whole blood samples were extracted and subjected  determine the reproducibility of the Invader   Factor V test  A single lot of the to bi directional DNA sequencing  The same DNA samples were then analyzed  Invader  Factor V test was used to compare the test performance at three using the Invader   Factor V test with three different lots of the reagents  The  different study sites  Blood samples for each genotype were extracted at each observed agreement between all three lots of the Invader   Factor V test and bi   site  DNA from the samples underwent subsequent Invader    analysis at each directional DNA sequencing was 100   60 60   see Table 8   Across all  site on each of fiv
5.  control and centrifuge plate briefly      sample of the reaction plate     Q  Or  Q    QQOQOOOOOO       19  Read the reaction plate on a multi well fluorometer according to the  manufacturer s instructions  Verify the parameters match Table 3        10  Dispense 10 uL of the appropriate control or  sample  genotype specific controls and all  samples are diluted  See step 3   Control 4   NDC  is undiluted  to bottom of the  appropriate well of the reaction plate  See    QQQOOOOG   QQQOOOOO   QQOOOOOCO   QQOOOOOOC   QQOQQOOOOG   QOQOOOOOO  QQOQOOOOOO   OOO00000        Table 3  Recommended Multi well Fluorometer Settings       Figure 2   Mix by pipetting up and down 3     5 Setting Category Measurement 1  FAM  Measurement 2  Red   times upon addition to ensure reaction  homogeneity  Change pipette tips between Mode  Fluorescence Top Reading Fluorescence Top Reading  every addition     Do not use    Plate with cover    option    11  Overlay all control and sample wells with 20 uL of fresh mineral oil by dispensing  along the side of the wells  Change pipette tips between every addition  archer aaa ak 485  20  nm 560  20  nm    12  Cover the reaction plate with optically clear adhesive film  Thoroughly secure the n   film to the surface of the plate  Emission Wavelength     Bandwidth         13  Visually confirm no bubbles exist in the reaction wells  If bubbles are visible        remove bubbles  e g   centrifuge plate briefly   Number of Reads  or flashes   10 10  14  Place the 
6.  use the product for new product research or development  product manufacture   or any reverse engineering purposes  The purchaser of this product is not authorized to transfer this  product to any third party for any purpose without the express written consent of Hologic  Inc   Except as expressly provided in this paragraph  no other license is granted expressly  impliedly  or  by estoppel  For information concerning the availability of additional licenses to practice the  patented methodologies  contact  Legal Department  Hologic  Inc   502 South Rosa Rd   Madison   WI  53719   608  273 8933     Page 8 of 9    U S  Patent Nos  5 691 142  5 792 614  5 846 717  5 985 557  5 944 069  6 090 543   6 121 001  6 110 677  6 348 314  6 368 803  6 458 535  6 555 357  6 562 611  6 673 616   6 872 816  6 875 572  6 913 881  7 011 944  7 067 643  7 087 381  7 195 871  7 273 696   7 306 917  7 354 708  7 381 530  7 407 782  7 514 220  and any corresponding international  equivalents     Vill LIMITED PRODUCT WARRANTY    WARRANTIES  Equipment  Supplies  and Software are warranted to the original Customer to  perform substantially in accordance with published Product Specifications for one  1  year  starting from the date of Installation  if applicable  or from the date of Delivery  whichever  occurs first  After sale options and accessories are warranted for six  6  months  and x ray  tubes are warranted on a straight line prorated basis as stated in the applicable Product  Specification  
7. HOLOGIC    Invader   Factor V  95 453  144 tests or 95 457  1680 tests    IVD    SG     In vitro diagnostic medical device    144 Contains sufficient reagents for 144 tests    1680 Contains sufficient reagents for 1680 tests     15  C    Temperature limitation    C  Principles and Procedures    The Invader   Factor V test utilizes the Invader Plus   chemistry with DNA isolated from  human whole blood  for the detection of the targeted sequence polymorphism  Specifically   the Invader Plus   chemistry utilizes a single tube  two phase reaction  including target  amplification and signal generation  mediated by Invader   chemistry   Invader Plus   reaction  mixes are assembled by combining the Factor V Oligo Mix  Universal Enzyme Mix  and  Universal Buffer  In a 96 well plate  reaction mix is combined with purified genomic DNA  samples  as well as four  4  controls included with the test  The No DNA Control is used by  the interpretive software to set the  noise  component of the run for  signal to noise   calculations  The genotype specific controls  WT  HET  MUT  ensure reagents were  assembled correctly and perform according to the specifications  The 96 well plate is  transferred to an appropriately programmed thermal cycler for target amplification and signal  generation  In the target amplification phase of the reaction  amplification is carried out  using  two step  cycling conditions  i e   denaturation  amp  annealing extension   Following  amplification  Taq polymeras
8. IMPORTANT CONTAMINATION PRECAUTIONS  This product generates  amplified DNA targets  When performing the test  caution must be taken to  prevent amplicon contamination of work areas  Always use barrier pipette tips  for pipetting procedures  Perform the amplification set up in an isolated area  with dedicated pipettes  Use tips and tubes that are DNase RNase free     C  Toxicity of Invader   Reagents    The Invader   Factor V test reagents are not controlled as dangerous substances and no  toxicity has been determined  A Material Safety Data Sheet is available upon request   Please call Hologic Technical Support at 888 898 2357 for a copy if needed     Invader   Factor V    IV  INSTRUCTIONS FOR USE    A  Invader   Test Step by Step Procedure    Software Set up    1     2            O    Open the Invader Call Reporter  software and complete the testing information   Details for using the software can be found in the software user manual  Software  User Manual for Invader    Factor V  MAN 01688      Enter the name of the operator   In the dropdown    Menu Selection    select the Factor V test   Enter the number of samples to be tested in the space provided     Click the    Proceed to Mix Preparation    button located in the lower right corner  of the window     On the Mix Preparation tab  fill in the green shaded boxes for Lot Numbers and  Expiration Dates for the reagents used during the testing     If desired click the    View Save PDF    button located in the upper right corn
9. W THE  EXCLUSION OF IMPLIED WARRANTIES SO THE ABOVE EXCLUSIONS MAY NOT APPLY  TO YOU  YOU MAY ALSO HAVE OTHER RIGHTS  WHICH VARY  FROM STATE TO  STATE  These warranties do not apply to any item that is   a  repaired  moved or altered other  than by Hologic authorized service personnel   b  subjected to physical  including thermal or  electrical  abuse  stress  or misuse   c  stored  maintained or operated in any manner  inconsistent with applicable Hologic specifications or instructions  or  d  designated as  supplied subject to a non Hologic warranty or on a pre release or  as is  basis     WARRANTY CLAIMS AND REMEDIES  In the event of any warranty claim  Hologic will  replace with new or repaired items any Equipment part  Component  or Consumable Supply  that is in breach of warranty  and will use reasonable efforts to promptly fix or provide a  workaround for any Software defect or bug which prevents operation in substantial conformity  with functional specifications  Alternatively  Hologic may elect to repay or credit to Customer  an amount equal to the purchase price of the defective Equipment  component  Software   consumable supply  or Service  Items replaced shall become Hologic property  All claims shall  be initiated by contacting Hologic within the applicable warranty period and thirty  30  days  after discovery of the breach or non conformity  Hologic must be given reasonable access and  an opportunity to inspect all associated materials  If Hologic and Customer a
10. able 2  or print out from Mix  Preparation tab of software  in a microcentrifuge tube     Page 3 of 9    E Note  The prepared reaction mixture must be used within 30 minutes     Note  Controls must be placed in the correct wells for proper data interpretation     Step   Description   Temperature    C    Time   Cvcles  Refer to Figure 2  p p    C   a T A  4    Table 2  Invader   Factor V Reaction Mix    Factor V Oligo Mix 7 5 uL    C Ameal   Extend E a a 1 5 Minutes  Polymerase    Figure 3  Invader Reaction Program     7 5k 1 25     Universal Bute a    2 0K1 25   Universal Enzyme Mix 0 5 uL pk   as  0 5k 1 25   Total Mix Volume   tom   K   128   012     7  Vortex the reaction mix thoroughly and spin down the contents in a 15  Start the Invader reaction program   microcentrifuge for 3 5 seconds  16        When the Invader reaction program is complete  the reaction plate can be held in  the thermal cycler at  10  C or stored in a refrigerator   2  C to  8  C   protected  from light  overnight     Plate Set up 1 Figure 2   8  Reaction mi peaini nioa oee Plate Data Collection  e eaction mix may be aliquoted into a 96 we a  plate to facilitate the use of a multi channel Position of 17  Allow reaction plate to equilibrate to room temperature on the bench top at least 1  pipettor  aera minute prior to reading plate   9  Add 10 uL of reaction mix to the bottom of plate 18  Visually confirm no bubbles exist  If bubbles are visible  remove bubbles  e g      each well designated for each
11. ded with the test  Genotype specific controls consist of synthetic DNA in a blood like  matrix  and are not infectious  Genotype specific controls must be extracted prior to use   and can serve as a DNA extraction control as well if prepared using the same method as  the blood samples  Prior to extraction  genotype specific controls should be vortexed  30   60 seconds  to re suspend the contents     Page 2 of 9    DNA Storage  The purified DNA from samples and genotype specific controls can be used  immediately or safely stored in elution buffer as per the DNA extraction kit manufacturer s  recommendation     DNA Preparation  Extracted clinical specimen and genotype specific control DNA must be  diluted 1 20 in nuclease free water just prior to running the Invader   Factor V test  see  Section IV A  3   The level of DNA present in the extracted genotype specific controls may    not be detectable with certain quantitation methods and    is not quantifiable by    spectrophotometer measurements     lll  SAFETY ISSUES    A  Safety and Handling Precautions    1     Universal safety precautions should be used when handling any human whole blood  samples  Specimens should be disposed of according to local requirements     Product components  product residuals and packaging  can be considered laboratory  waste  Dispose of unused reagents and waste in accordance with applicable federal   state  and local regulations     B  Precautions    A       s    The Invader   Factor V test is int
12. e  5  non   consecutive days  Results were obtained using the genotypes tested  across all three  3  lots  the overall agreement with bi   Factor V Invader Call Reporter    software  see Tables 6 and 7   directional sequencing was 100   60 60   with 95 13   one sided lower 95     Table 6  a Reproducibility of Invader    Factor V Test confidence limit     Final  Following Single Retest  Final   Table 8  Lot to Lot Agreement between Invader   Factor V Test and Bi directional DNA  Samples  __  Calls No Calls Agreement  Operator Sous Correct  EQ  Samples Tested  ene 0    Sequencing  Site 100     Correct       Invalid calls in  z genotype calls Cran   100  in 1  run Percent   100    100     Agreement  100     98 89   99 81    Eighteen  18  of these    No Call    results were due to an    Invalid Control    result on a single run  Upon an    Invalid Control    result  the call reporting  software automatically prevents the display of all sample genotypes  which resulted in 18    No Call    samples  Upon retraining of the Operator  and  retesting  see Figure 4  of the run  all controls reported    Valid    and all 18 samples were found to be in agreement with sequencing     Upon re extraction  and re testing this sample was found to be in agreement with sequencing     Factor V  Genotype   bi directional  sequencing     Number of Replicates  Genotypes per  tested sample    Homozygous  Wild Type   GG   G n                                               Table 7  Invader  Factor V Test S
13. e is inactivated by a 10 minute incubation at 99  C  after which  the thermal cycler proceeds to 63  C to initiate the signal generation  Invader    phase of the  reaction  see Figure 1      INDICATIONS AND USE  MATERIAL AND METHODS  SAFETY ISSUES  INSTRUCTIONS FOR USE  BIBLIOGRAPHY   CONTACT INFORMATION    1a  Structure Formation   Wildtype Specific Primary Probe    2a  Structure Formation   Mutation Specific Primary Probe    Uia    NOTICE TO RECIPIENT ABOUT LIMITED LICENSE  LIMITED PRODUCT WARRANTY    l  INDICATIONS AND USE    A     Intended Use    The Invader   Factor V test is an in vitro diagnostic test intended for the detection and  genotyping of a single point mutation  G to A at position 1691  of the human Factor V gene  in isolated genomic DNA obtained from whole blood potassium EDTA samples from patients  with suspected thrombophilia       Clinical Significance    The Factor V Leiden  FVL  mutation refers to a base change from guanine  G  to adenine   A  at position 1691 in the gene coding for the Factor V protein  an amino acid substitution  that eliminates one of three activated protein C cleavage sites in Factor V  As a result   Factor V is inactivated to a lesser extent and persists for a longer period in the circulation   leading to more thrombin generation    In the United States  a single FVL allele is present in  about 5  2 2  and 1 2 percent of the Caucasian  Hispanic  and African American populations   respectively  overall  about 1 in 5 000 individuals i
14. ended for in vitro diagnostic use    These components have been tested as a unit  Do not interchange components from  their sources or from different lots  Do not pool reagents from different lots or from  different vials of the same lot    Take reasonable precautions when handling reagents  Use disposable gloves when  handling suspected carcinogens or toxic materials    Do not smoke  eat or drink in areas where specimens or reagents are being handled   Avoid contact of eyes and mucous membranes with reagents  If reagents come in  contact with sensitive areas  wash with copious amounts of water    Patient specimens and all materials coming into contact with them should be handled as  if capable of transmitting infection and disposed of with proper precautions  Never pipette  by mouth and avoid contact of reagents and specimens with skin and mucous  membranes    Avoid microbial contamination of reagents as this could produce incorrect results   Incubation times and temperatures other than those specified may give erroneous  results    The reagents have been optimally formulated and further dilution may result in loss of  performance    Do not use reagents after their expiration date    Use fresh mineral oil for each reaction set up  do not transfer these reagents back to the  original container once they have been dispensed     The provided genotype specific controls are in a blood like matrix and are not infectious   Material can be used in a Bio Safety Level 1 laboratory    
15. er of  the window  Print the PDF and then close the PDF window     On the Sample Placement tab  enter the Sample IDs into the list on the left side  of window  The Sample ID list runs down columns  i e   wells E1 through H1   followed by A2 through H2  and then A3 through H3         Verify all samples are entered in the list and are in correct position of the  sample grid     If desired click the    View Save PDF    Button located in the upper right corner of  the window  Print the PDF and then close the PDF window     Close the Invader Call Reporter   software     Confirm the thermal cycler is programmed as stated in Figure 3     Sample Preparation  1 20 Dilution     3     Dilute extracted genotype specific controls and all extracted sample DNA  1 20   using 5 uL of genotype specific control sample and 95 uL nuclease free water in a  0 5 mL tube or similar consumable  Mix the diluted genotype specific  controls samples thoroughly  Do not dilute the No DNA Control  Control 4  prior to  use     Mix Preparation    4     Remove the reagents  Oligo Mix  Universal Buffer  No DNA Control  from their  respective storage locations and allow them to equilibrate to room temperature for  approximately 30 minutes  Do not remove the Universal Enzyme Mix from the    30  C to  15   C freezer until just prior to use     Vortex the components of the reaction mix thoroughly and spin down the contents  in a microcentrifuge for 3     5 seconds     Combine components of reaction mix as shown in T
16. erol   300 mg dL human whole blood   potassium EDTA  1 8 mg mL human whole blood    hemoglobin  up to 0 2  in whole blood   and ethanol based wash buffer  5  in DNA sample   had no impact on Invader   Factor V performance     F  Troubleshooting  Table 9  Troubleshooting Guide    Errors occur during data  import       Check FAM  amp  Red gain  settings and read the whole  plate again   Partial plate reads  are not allowed           Check FAM gain setting and  read the whole plate again    Partial plate reads are not  allowed           Check Red gain setting and  read the whole plate again    Partial plate reads are not  allowed         See Invader Call Reporter     Invader   Factor V software  User Manual troubleshooting  guide     Fluorometer issues     Verify that the Invader  Reaction Program is as  specified  Section IV A  Figure  3      Re run test taking care not to  Contamination contaminate samples or  reagents   Remove bubbles  e g    Bubbles in reaction well  centrifuge plate briefly  and re   read   l   Remove bubbles  e g      Vortex each reagent before  adding to reaction mix   Verify correct reagent volumes  were added to the reaction  mix    Verify all reagents were added  to the reaction mix    Vortex reaction mix before  adding to the 96 well plate   Visually confirm that no  volume discrepancies exist in  the 96 well plate by viewing  the bottom side of the plate     Incubation period was longer  than specified length of time  recommended     High No DNA Cont
17. ick the    View Save PDF    button located in the upper right corner of  window  Print the PDF  and then close the PDF window     29  Click on the    Summary    tab to view sample validity and genotype results     30  If desired  click the    View Save PDF    button located in the upper right corner of  window  Print the PDF  and then close the PDF window     31  If desired  click the    Finish Active Assay    button to delete run information when  testing and analysis is completed     B  Quality Control Procedures    Differences in blood processing and technical procedures in the user   s laboratory may produce  variability in results  necessitating regular evaluation of laboratory designated controls in  addition to the following procedures     Prior to initial use of this test in the user s laboratory  the performance of the test may be verified by  testing a number of positive and negative samples with known characteristics  These quality control  tests should be repeated for each new lot or a change in test parameters     Test verification on a daily basis may be accomplished through the proper use of the above   mentioned laboratory designated controls  as described in this section     The No DNA Control  C4  is used to establish the amount of signal generated in the absence of  target     Test runs are valid when the genotype specific controls yield the appropriate genotype results   Table 4   If any of the genotype specific controls are called incorrectly or EQ  equiv
18. isually confirm that no volume  discrepancies exist in the 96   well plate by viewing the  bottom side of the plate    Verify concentration of at least  5ng uL prior to dilution and  reaction set up     Verify 1 20 dilution made  correctly  Sample Preparation  section IV A     If the DNA concentration is  lt 5  ng uL pre dilution  repeat the  DNA extraction and purification  protocol to obtain purified DNA  at a higher concentration   Repeat sample with Invader    Factor V test     Remove bubbles  e g    Bubbles in reaction well  centrifuge plate briefly  and re    read    Repeat DNA extraction from   specimen     Refer to package insert  performance characteristics    Interfering substances Section  IV E 4      Verify 1 20 dilution made  DNA sample inhibition correctly  Sample Preparation  section IV A      Verify that no volume  discrepancies exist in the 96   well plate by viewing the  bottom side of the plate              Insufficient sample DNA used  in the reaction             Result for sample is    Low  Signal        EQ    or    Invalid               DNA sample inhibition    Result for sample is    Low  Signal        EQ    or    Invalid       Incorrect sample volume or no  sample added to well        Page 7 of 9    Table 9  Troubleshooting Guide    Improper preparation of  reaction mix    Evaporation of reaction  mix sample during run     Result for sample is    Low  Signal        EQ    or    Invalid       Insufficient DNA amplification        96 well plate incompatib
19. le with  thermal cycler or positioned  incorrectly within thermal    cycler     Sample DNA degradation   DNA may degrade if stored at    room temperature         Troubleshooting Re test Procedure       Vortex each reagent before  adding to reaction mix     Verify correct reagent volumes  were added to the reaction    AT all reagents were added  to the reaction mix     Vortex reaction mix before  adding to the 96 well plate    Visually confirm that no  volume discrepancies exist in    the 96 well plate by viewing  the bottom side of the plate   Verify reactions are covered by  20 uL of mineral oil   Verify the 96 well plate is firmly  sealed with optical clear  adhesive cover before  incubating    Verify thermal cycler heated lid  is firmly closed   If the thermal cycler requires a  compression pad  verify that  the compression pad is seated  properly on top of the 96 well  plate    Verify the correct Invader  Reaction Program was used   Section IV A  Figure 3    Repeat sample test    Verify all reagents have been  added to reaction                Verify the 96 well plate is  compatible with the thermal  cycler  is firmly seated in the  thermal cycler and secured  properly     Store extracted DNA as  indicated in the DNA extraction  and purification protocol prior  to the Invader  test        If the established criteria for an acceptable genotype call  i e   WT  HET  or MUT  are not met by  a given sample  it is identified as either    Low Signal    or    EQ    and the sample 
20. nalysis  such as specific methods and compositions  for manipulating or visualizing nucleic acids for analysis  may be covered by one or  more patents owned by other parties  Similarly  nucleic acids containing specific  nucleotide sequences may be patented  Making  using or selling such components or  nucleic acids may require one or more licenses  Nothing in this document should be  construed as an authorization or implicit license to make  use or sell any so covered  component or nucleic acid under any such patents       2011 Hologic  Inc   Part Number 15 3217  Revision 100    Page 9 of 9    
21. ocal   the run is  invalid and must be repeated  A test run with invalid control results will fail to provide sample results   In the event of a control failure  all samples in the run should be re tested     Unexplained discrepancies in control results should be referred to Hologic Technical Support   888 898 2357   See the Troubleshooting section of this package insert for additional  information     Invader   Factor V       Homozygous Mutant    All quality control requirements should be performed in conformance with local  state  and or federal  regulations or accreditation requirements     C  Interpretation of the Results    Results from the Invader   Factor V test are reported to the user as a genotype    call     indicating  which genotype was detected in the sample  WT  HET  MUT   The results also report sample  validity and run validity  Genotype calls and corresponding nucleotides are shown in Table 4        Table 4  Interpretation of Results    Nucleotides at  Genotype Invader   Factor V Genotype Call Position 1691      Homozygous WildType   wr   n        e l ee   AA   The Results in the Invader Call Reporter   software display sample and control data  If results    are invalid or not displayed  refer jo the Troubleshooting section of this package insert and the  Software User Manual for Invader   Factor V  MAN 01688      Heterozygous    The    Summary    tab in the Invader Call Reporter   software displays results for all samples and  controls in a condensed format
22. pettors  multichannel  pipettor  microcentrifuge  vortex mixer      E  Storage and Handling    F     NOTE  Product requires multiple storage temperatures for reagents     Immediately upon receipt  genotype specific controls are to be stored at  2  C to   8  C  All other components of the kit should be stored between  30  C to  15  C Ina  non frost free freezer     Prior to use  allow reagents to equilibrate to room temperature  excluding the Universal  Enzyme Mix which should remain between  30  C to  15  C until just prior to use  Minimize  reagent exposure to light  Do not subject the reagents to more than 15 freeze thaw cycles     Indications of Instability    When properly stored  the reagents are stable through the dating indicated on the label   There are no obvious signs to indicate instability of this product  However  genotype   specific controls should be included on each run  as an increase in non specific  fluorescence signal may indicate reagent instability  If this is observed  contact Hologic  Technical Support  888 898 2357      G  Specimen Collection and Preparation for Analysis    Clinical Specimens  Human whole blood samples should be anti coagulated with  potassium EDTA  DNA extraction may be accomplished using commercially available DNA  extraction chemistries  capable of obtaining DNA concentrations greater than 5ng uL for  use in the Invader   Factor V test     Genotype Specific Control Samples  Genotype specific  i e   WT  HET  MUT  controls are  provi
23. re unable to settle  any claim and Customer has not notified Hologic within one  1  year after the claim arises   Customer shall be barred from instituting any legal action thereafter  These remedies shall  comprise Hologic s entire liability and Customer s exclusive remedy for breach of warranty and  are in lieu of any other remedies at law or equity     Invader   Factor V    LIMIT OF LIABILITY  HOLOGIC SHALL NOT BE LIABLE FOR ANY SPECIAL  INCIDENTAL   PUNITIVE  EXEMPLARY OR CONSEQUENTIAL LOSSES  DAMAGES  OR EXPENSES   INCLUDING BUT NOT LIMITED TO LOSS OF PROFITS  DATA  OR USE   DIRECTLY OR  INDIRECTLY ARISING FROM THE SALE  HANDLING  SERVICE OR USE OF PRODUCT  ORDERED OR FURNISHED  OR FROM ANY CAUSE RELATING THERETO UNLESS  EXPRESSLY AGREED TO BY THE PARTIES IN WRITING  EXCEPT FOR PERSONAL  INJURY OR DEATH TO THE EXTENT RESULTING FROM HOLOGIC   S NEGLIGENT OR  INTENTIONALLY WRONGFUL ACTS OR OMISSIONS  IN NO EVENT SHALL HOLOGIC BE  LIABLE UNDER ANY LEGAL THEORY OR FOR ANY CAUSE WHATSOEVER  WHETHER  BASED UPON WARRANTY  CONTRACT  TORT  NEGLIGENCE  OR OTHER THEORY   EVEN IF ADVISED OF THE POSSIBILITY THEREOF  FOR ANY AMOUNT IN EXCESS OF  THE PRICE  FEE OR CHARGE THEREFORE RECEIVED BY HOLOGIC     Cleavase    Invader    Invader Plus   and Invader Call Reporter   are registered trademarks of  Hologic  Inc  All other Trademarks   Registered Trademarks referenced within this product  insert are the property of each of their respective companies     Some components of nucleic acid a
24. reaction plate in the thermal cycler  Integration Time  20 us 20 us  Lag Time  0 us O us  Settle Time   Multiple Reads per Well  Not selected Not selected  Label Name  Label 1 Label 2    Invader  Factor V Page 4 of 9    20  Place the 96 well plate to be analyzed onto the plate carrier with the A1 well  oriented to the upper left corner of the plate carrier  Do not remove the optically  clear adhesive film from the surface of the plate  Read the entire plate according  to manufacturer s instructions     FAM or Red fluorescence  re read the plate adjusting the gain setting s   accordingly so that each value is greater than 600 counts and the reader is in  the linear dynamic range according to the manufacturer   s instructions     j NOTE  If the No DNA Control  NDC  signal is not greater than 600 counts for    Data Analysis  21  Open the Invader Call Reporter   software     22  Select the plate s  to be analyzed by highlighting the appropriate row in the blue     Active Assay    field     23  Click the    Load Selected    button in lower left area of the window  This should  allow the    Results    tab to be selected     24  Click on the    Results    tab     25  Select the Raw Data File by clicking on the    Select File    button and select the  appropriate file in the browser     26  Select the appropriate Worksheet in the raw data file from the available choices in  the dropdown menu     27  Click the    Import Raw Data    button to populate data fields     28  If desired  cl
25. rol FAM or  Red Signal         Incorrect control volume or no  control added to well                 No DNA Control is Invalid   Result for one or more  Genotype specific Control is  Invalid              Evaporation of reaction  mix sample during run     Verify reactions are covered by  20 uL of mineral oil        Use DNase RNase free  aerosol barrier tips at all times   Do not allow pipette tips to  touch any surface except the  solution being pipetted        Evidence of contamination  during genotype specific  control preparation or reaction  mix preparation     No DNA Control is Invalid   Result for one or more  Genotype specific Control is  Invalid       Use sterile tubes for preparing  reaction mixes     Wear gloves at all times    Invader   Factor V             Table 9  Troubleshooting Guide    Controls in wrong location on  plate    Verify control well location     Section IV A  Figure 2   Gain setting too low  NDC    Adjust gain setting so NDC is  value  lt 600 counts   above 600 counts   Genotype specific controls not quae clash  asaracied controls using standar   laboratory method     Vortex each reagent before  adding to reaction mix                  No DNA Control is Invalid   Result for one or more  Genotype specific Control is    Invalid Verify correct reagent volumes    were added to the reaction  mix     Improper preparation of  reaction mix    Verify all reagents were added  to the reaction mix     Vortex reaction mix before  adding to the 96 well plate     V
26. s  must be re   tested  A given extraction of a sample that has two EQ  equivocal  results in a row cannot be  called by the Invader   Factor V test  If a sample fails to produce the minimum fold over zero  then the Invader test gives a    Low Signal    result  and the sample must be re tested  Figure 4  illustrates the sample re test process for samples with    Low Signal        EQ    or    Invalid    results     Invader   Factor V                         Do Invader    controls all generate  valid results          ReRun Invader    test on controls  and invalid  samples    Do samples all  generate valid  results     Extract controls Run Invader   test Analyze Invader    and samples test results                            A              Do Invader    controls all   generate valid  results           Do samples all  generate valid  results                              Figure 4  Recommended testing process for samples producing    Low Signal        EQ    or    Invalid    results  with the Invader   Factor V test     V  BIBLIOGRAPHY    1  Lee R  Factor V Leiden  a clinical review  Am J Med Sci  2001 322 88 102    2  Kujovich JL  Factor V Leiden Thrombophilia  GeneReview on GeneTests  Last Updated 2 17 07    htto   www ncbi nim nih gov bookshelf or fcgi book gene amp part factor v leiden    3  Anderson FA Jr  Wheeler HB  Goldberg RJ  et al  A population based perspective of the hospital  incidence and case fatality rates of deep vein thrombosis and pulmonary embolism  The Worcester
27. s homozygous for the mutation      The  FVL mutation has been estimated to be present in 15 to 20 percent of patients with first  venous thromboembolism  VTE   and is the most common heritable prothrombotic risk  factor in the United States  In population based studies  FVL increases the risk of a first VTE  4  to 7 fold in heterozygous individuals and 40  to 80 fold in homozygous individuals         Invader   Factor V    X X  A aiian mmu Yi anii o gt  B abaia mu Yi  Kii    aid it Seem wre                 i l J  i TARGET i   TAREE  a 1 TARGET A TAREE     1b  Structure Recognition  and Cleavage     2b  Structure Recognition  and Cleavage     FLUORESCENCE 2  FAM       FLUORESCENCE 1   RED    Figure 1  Invader   Signal Generation Phase    Page 1 of 9    During the signal generation phase  a discriminatory Primary Probe transiently hybridizes to  the amplified target sequence along with an Invader  oligonucleotide  to form an overlapping  structure  The 5  end of the Primary Probe includes a 5  flap that does not hybridize to the  target DNA  The 3  nucleotide of the bound Invader   oligonucleotide overlaps the Primary  Probe  and does not hybridize to the target DNA  The Cleavase   enzyme recognizes this  overlapping structure and cleaves off the unpaired 5  flap of the Primary Probe  releasing it  as a target specific product  The Primary Probe is designed to have a melting temperature  aligned with the Invader   reaction temperature so that under the isothermal reaction  condi
28. tions   63  C  the Primary Probes cycle on and off the target DNA  This allows for  multiple rounds of Primary Probe cleavage for each DNA target resulting in an accumulation  of the number of released 5  flaps  The released 5    flap transiently hybridizes with a  corresponding FRET cassette forming an overlapping structure that is recognized and the  fluorophore is cleaved from the FRET cassette by the Cleavase   enzyme  The 5    flap is  designed to have a melting temperature aligned with the Invader   reaction temperature  so  that the 5    flaps cycle on and off of the corresponding FRET cassettes  This allows for  multiple rounds of FRET cassette cleavage for each 5 flap  and an accumulation of  released fluorophore  When the FRET cassette is cleaved  a fluorophore and quencher are  separated  generating detectable fluorescence signal  The format uses two different  discriminatory Primary Probes  one for the mutant allele and one for the wild type allele   Figure 1   Each Primary Probe is assigned a unique 5  flap  and distinct FRET cassette   with a spectrally distinct fluorophore  By design  the released 5  flaps will bind only to their  respective FRET cassettes to generate a target specific signal  linking the wild type allele  with one fluorophore  Fluorescence 1  RED  and the mutant allele with the second  fluorophore  Fluorescence 2  FAM      ll  MATERIALS AND METHODS  A  Reagents Provided    Table 1  Reagents Provided       Reagent Vial Label Abbreviation    Fac
29. tor V Oligo Mix None    Universal Buter   B  Universal Enzyme Mix       Invader   Factor V WT None    Invader   Factor V HET   None      Invader   Factor V MUT None    No DNA Control    B  Reaction Mix       All of the Invader   Factor V reagents are supplied in concentrations ready for use  The  amount of reagents required for each reaction is summarized in Table 2  Make sure to mix  reagents well prior to use     Invader   Factor V    Other Materials Provided  Invader Call Reporter   software and Invader   Factor V software  Software User Manual for Invader   Factor V  MAN 01688     Both software programs and the software user manual are provided along with the first  order shipment of the Invader   Factor V test  Contact Hologic Technical Support  888 898   2357  if an additional copy is needed     Materials and Reagents Needed But Not Provided     Thermal cycler with heated lid capable of holding set temperatures within     1  C      Multi well Fluorometer  See Software User Manual for Invader   Factor V  MAN 01688 for   fluorometer software specifications      Computer  See Software User Manual for Invader   Factor V  MAN 01688  for computer   specifications      Pipette tips  filter barrier     96 well plates     Optically Clear Adhesive Plate sealers       Nuclease free water     Mineral oil     Microcentrifuge tubes      Commercially Available DNA Extraction kit  or validated in house laboratory method        General laboratory equipment as needed  tube racks  micropi
30. ummary of Agreement Data for all Three Sites  3  Upper and Lower Limits of Detection        One Sided  Lower 95   Confidence  Limit                Forty  40  replicates of genomic DNA samples representing the wildtype and heterozygous  Factor V genotypes were tested at concentrations of both 5 ng uL and 80 ng uL  prior to 1 20  dilution for the Invader reaction  and the Invader results compared to bi directional sequencing   For each concentration  there was 100   80 80  agreement with bi directional sequencing   9  samples  Across all genotypes tested  for a given DNA concentration  the one sided lower 95   Within Operator x 2  operators  270 100  99 0  confidence limit was 96 32   Samples were also tested beyond the recommended   Within day  x 5  days  ij   concentrations of DNA  at 10 fold extremes of the recommended range  e g   0 5 ng uL and 800   x 3  sites    270 ng uL   At these extreme concentrations  there was 100   80 80  agreement at 0 5 ng uL and   100   80 80  agreement at 800 ng uL concentrations     Percent  Agreement    Number of  Agreements    Number of    Analyses    y Comparisons    9  samples   x 10  day pairs   Between days x 4  2 reps per a   Within Operator  day  2160 100  99 6     x 2  operators   x 3  sites    2160    Between  9  samples   operator x 4  2 reps per 2700 100  99 6    within site  paisa    Invader   Factor V Page 6 of 9    4  Interfering Substances    Heparin  1500 U dL human whole blood   bilirubin  10 mg dL human whole blood   cholest
    
Download Pdf Manuals
 
 
    
Related Search
    
Related Contents
AudioSonic CD-1592 CD radio  Philips SHL2800 Lightweight Headphones  Peavey Electronics Audio Performer Pack  Liquid Airborne Spray/Liquide Pour Vaporisation  User`s Manual (Administrator`s Version)  XPW-211ROOM 追加取扱説明書    Copyright © All rights reserved. 
   Failed to retrieve file